Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Borchmann

Showing results (21-30 of 252) with videos related to

Pageof 26
Sort By:
Leukemia & Lymphoma|June 1, 2016
Current and future immunotherapeutic approaches in Hodgkin lymphomaPaul J Bröckelmann, Peter Borchmann, Andreas Engert
Nature Reviews. Clinical Oncology|June 13, 2012
State of the art in the treatment of Hodgkin lymphomaPeter Borchmann, Dennis A Eichenauer, Andreas Engert
Current Opinion in Investigational Drugs (London, England : 2000)|January 15, 2005
Monoclonal antibody-based immunotherapy of Hodgkin's lymphomaPeter Borchmann, Roland Schnell, Holger Schulz, et al.
Onkologie|September 17, 2011
[Lymphatic neoplasias in young patients]Peter Borchmann, Nicola Gökbuget, Gerald Wulf, et al.
Lancet (London, England)|October 18, 2025
Glofitamab with GemOx for diffuse large B-cell lymphomaPeter Borchmann, Ron D Jachimowicz, Bastian von Tresckow
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Treatment of advanced-stage hodgkin lymphoma: let us face the factsPeter Borchmann, Stefanie Kreissl, Volker Diehl, et al.
The Lancet. Oncology|October 2, 2025
BrECADD and fertility: an ongoing concern - Authors' replyJustin Ferdinandus, Janina Jablonski, Peter Borchmann, et al.
Expert Review of Hematology|November 19, 2010
Hodgkin's lymphoma: current treatment strategies and novel approachesDennis A Eichenauer, Michael Fuchs, Peter Borchmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2020
Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma NichePaul J Bröckelmann, Sven Borchmann, Peter Borchmann, et al.
Hematological Oncology|June 15, 2025
Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Update on Biology and TreatmentPeter Borchmann, Dennis A Eichenauer, Gerard Frigola, et al.
Pageof 26

Showing results (21-30 of 252) with videos related to

Sort By:
Pageof 26
Leukemia & Lymphoma|June 1, 2016
Current and future immunotherapeutic approaches in Hodgkin lymphomaPaul J Bröckelmann, Peter Borchmann, Andreas Engert
Nature Reviews. Clinical Oncology|June 13, 2012
State of the art in the treatment of Hodgkin lymphomaPeter Borchmann, Dennis A Eichenauer, Andreas Engert
Current Opinion in Investigational Drugs (London, England : 2000)|January 15, 2005
Monoclonal antibody-based immunotherapy of Hodgkin's lymphomaPeter Borchmann, Roland Schnell, Holger Schulz, et al.
Onkologie|September 17, 2011
[Lymphatic neoplasias in young patients]Peter Borchmann, Nicola Gökbuget, Gerald Wulf, et al.
Lancet (London, England)|October 18, 2025
Glofitamab with GemOx for diffuse large B-cell lymphomaPeter Borchmann, Ron D Jachimowicz, Bastian von Tresckow
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Treatment of advanced-stage hodgkin lymphoma: let us face the factsPeter Borchmann, Stefanie Kreissl, Volker Diehl, et al.
The Lancet. Oncology|October 2, 2025
BrECADD and fertility: an ongoing concern - Authors' replyJustin Ferdinandus, Janina Jablonski, Peter Borchmann, et al.
Expert Review of Hematology|November 19, 2010
Hodgkin's lymphoma: current treatment strategies and novel approachesDennis A Eichenauer, Michael Fuchs, Peter Borchmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2020
Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma NichePaul J Bröckelmann, Sven Borchmann, Peter Borchmann, et al.
Hematological Oncology|June 15, 2025
Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Update on Biology and TreatmentPeter Borchmann, Dennis A Eichenauer, Gerard Frigola, et al.
Pageof 26